Daudi In Vitro Anti-Tumor Efficacy Assay

CAT#: ITS-1022-YF1992
Target Cell Organism: Human
Target Cell Name: Daudi
Assay Type: Oncology Efficacy Assays
Assay Overview
This assay is to provide Daudi-based In Vitro Anti-Tumor Efficacy Assay to accelerate our client's oncology projects. The assay will be customized according to the specific requirements. Please contact our scientists to discuss more details.
Target Cell Name
Daudi
Target Cell Organism
Human
Target Cell Background
The Daudi cell line is composed of B lymphoblasts isolated from the peripheral blood of a Black,16-year-old, male, Burkitt's Lymphoma patient in 1967. These well-characterized B lymphoblasts have been extensively used in the study of leukemogenesis.
Related Diseases
Burkitt's Lymphoma
Research Area
Oncology
Assay Name
In Vitro Anti-Tumor Efficacy Assay
Short Description
Daudi-cell based In Vitro Anti-Tumor Efficacy Assay
Assay Description
Tumor-derived cell lines have been the mainstay for anti-cancer drug discovery, and the assessment of in vitro efficacy is a common method to evaluate the anti-cancer efficacy with various kinds of therapeutic candidates.
Assay Type
Oncology Efficacy Assays
For Research Use Only | Not For Clinical Use
Online Inquiry